Merck Riled In Tax Dispute With U.S. And Canada

Law360, New York (November 8, 2006, 12:00 AM EST) -- Pharmaceutical giant Merck & Co. disclosed on Tuesday that in addition to other woes, liabilities from four tax disputes in North America could cost it a total of $5.58 billion.

Tax authorities in the United States and Canada have cracked down on Merck’s practice of “transfer pricing.” Transfer pricing relates to the practice of reporting large amounts of revenue in a low-tax jurisdiction or large amounts of expenses in a high-tax jurisdiction, thus lowering taxable income.

Merck’s filing with the Securities and Exchange Commission mentions, among...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.